SCHEMBL23762208

SCHEMBL23762208

CC(C)(C)OC(=O)N1CCc2ccc(Oc3ccnc4c3c(-c3cc(N)no3)cn4COCC[Si](C)(C)C)cc2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.41
▸ ACACB O00763 1/20 0.35
▸ ESR2 Q92731 1/20 0.34
▸ MAPT P10636 4/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ BTK Q06187 1/20 0.32
▸ NAMPT P43490 1/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ PTK2 Q05397 1/20 0.32
▸ P2RX3 P56373 2/20 0.31
▸ ABCB1 P08183 3/20 0.31
▸ USP30 Q70CQ3 1/20 0.30
▸ F10 P00742 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29836527 1.00 NR1H2 (0.41) NR1H2ACACBESR2MAPTKDM4E
SCHEMBL23762209 0.92 NR1H2 (0.40) NR1H2ACACBESR2MAPTKDM4E
SCHEMBL23751127 0.92 NR1H2 (0.37) NR1H2ACACBESR2MAPTKDM4E
SCHEMBL23751189 0.91 MAPT (0.34) MAPTKDM4EALDH1A1HPGDTSHR
SCHEMBL23751196 0.90 NR1H2 (0.36) NR1H2ACACBESR2MAPTKDM4E
SCHEMBL23762097 0.88 ACHE (0.39) NR1H2ACACBESR2MAPTKDM4E
SCHEMBL23762199 0.87 NR1H2 (0.40) NR1H2ACACBESR2MAPTBTK
SCHEMBL29836532 0.87 NR1H2 (0.40) NR1H2ACACBESR2MAPTBTK
SCHEMBL23762188 0.87 KDM4E (0.38) NR1H2ACACBMAPTKDM4EALDH1A1
SCHEMBL29836482 0.87 NR1H2 (0.34) NR1H2ACACBESR2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210253568-A1 AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2021-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253568-A1 AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS ROCK1, ROCK2, RHOA NR1H2 1422/4885ACACB 2494/4885ESR2 3940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback